NASDAQ | TSX: ACB
Additions to product lineup include snackable
edibles, bold flavoured vapes, signature hash and an original
flower strain
EDMONTON, AB, June 6, 2023
/PRNewswire/ - Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the
Canadian company opening the world to cannabis, is launching a
fresh lineup of innovative products, available to patients on
Aurora Medical and consumers, at retailers across the country this
summer. The company's ever-expanding portfolio includes new 1mg
format, snackable edibles, premium resin vape carts with big, bold
flavour, and a true-to-form signature hash. New flower products
include Chemango Kush, an original strain from Occo,
Aurora's esteemed breeding program, as well as 14g format
extensions on popular strains, Moon
Berry and Pink Diesel.
"We continue to evolve our portfolio with the consumer and
patient top-of-mind, developing products that deliver on both
current and future wants and needs," says Lana Culley, Vice President of Product
Development at Aurora Cannabis. "With the introduction of
innovations like our snackable, low dose Lil' Bits and our XL
premium resin vape pens, we're ensuring consumers and patients can
find within Aurora's family of brands superior products as they
progress on their cannabis journey. The success of our Canadian
innovation is applicable in key markets internationally and is
receiving very positive patient feedback."
In addition to leveraging Aurora's best-in-class genetics
breeding and research program, the company has launched
Aurora Lab, an
exclusive experiential research and education program designed to
strengthen two-way conversations with patients, retailers,
budtenders and consumers. Through Aurora
Lab, partners get behind-the-scenes access and sneak peeks
at new products and formats, while invited patients get a chance to
trial unreleased products in exchange for feedback. Insights
gleaned from the program will be used to develop future products
and inform Aurora's innovation pipeline.
New products launching this summer include:
Daily Special:
- Lil' Bits Sour Grape & Sour Watermelon (10 x 1mg edibles) –
These low dose edibles deliver delicious flavour in a snackable
size, perfect for new users or for micro-dosing. Featuring
nostalgic, crowd-pleasing flavours with minimal to no cannabis
aftertaste. Available in recreational channel only.
- Mango XL Vape (510 - 1.2g) – A truly XL vape experience, both
in size and flavour, with nearly 1,000mg of THC per cart. Mango XL
uses a proprietary premium resin blend enhanced with botanical
terpenes for a broad-spectrum, full-flavour experience. Combine
that with a super-sized 2mm aperture for huge clouds.
- Signature Hash (2g) – A revolutionary bubble hash blend that
sets a new standard for malleability and burnability. Say goodbye
to harsh and brittle dry sift hash with our unmatched potency at an
affordable price.
San Rafael '71:
- Chemango Kush (3.5g flower) – A larger, fruitier, higher
potency version of Pink Kush, bred from proprietary Occo genetics
for the discerning strain-seeker. Chemango Kush delivers an
incredible aroma of fruit, sour and chem, with 24-30% THC. Very
dense trichome coverage results in high-potency and 2-4% terpenes.
Hang-dried, hand-finished and hand-bottled for an excellent final
product.
- Mondo Grapes Live Resin Gummies (4 x 2.5mg) – Made from
premium-quality, strain-specific Mondo
Grapes live resin extract from fresh-frozen flower. These
gummies are a complement to our flavour-forward gummy portfolio
delivering a delicious sweet grape flavour. Perfect for those
looking for a strain-specific edible experience.
- Tangerine Dream Cured Resin Vape (1g) – Made from our famously
flavourful Tangerine Dream flower, this vape delivers a
citrusy-sativa profile perfect for any time of day. Our hydrocarbon
extraction process results in a broad spectrum, true to strain
experience.
Greybeard:
- BIOFUEL Cured Badder (1g) – From the brand named "Concentrate
and Extract Company of the Year" by Kind Magazine, BIOFUEL brings
an aroma of gas, dough and sours, extracted using Greybeard's
proprietary closed-loop hydrocarbon extraction process for a
true-spectrum product without additives. This high-end concentrate
delivers tremendous value and a versatile format that can be
consumed many ways.
The summer product release is set to roll out to patients on
Aurora Medical and in adult-use retailers starting in June. Select
products are available in certain regions.
About Aurora:
Aurora is opening the world to cannabis, serving both the
medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as well
as CBD brands, Reliva and KG7. Medical cannabis brands include
MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as
well as international brands, Pedanios, Bidiol and CraftPlant.
Aurora also has a controlling interest in Bevo Farms Ltd.,
North America's leading supplier
of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products,
Aurora's brands continue to break through as industry leaders in
the medical, performance, wellness and adult recreational markets
wherever they are launched. Learn more at www.auroramj.com and
follow us on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward-looking
Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements with respect to
product innovation and new products to market, competitive
advantages including breeding and genetics and consumer research,
and the expected timing for the release of new products in the
medical and recreational channels.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and non-government consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations, management's estimation that SG&A will grow only in
proportion of revenue growth, the ability to expand and maintain
distribution capabilities, the impact of competition, the general
impact of financial market conditions, the yield from cannabis
growing operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws,
rules, and regulations in the industry, epidemics, pandemics or
other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out
under the heading "Risk Factors" in the Company's annual
information form dated September 20,
2022 (the "AIF") and filed with Canadian securities
regulators available on the Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that
the list of risks, uncertainties and other factors described in the
AIF is not exhaustive and other factors could also adversely affect
its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such
information. The Company is under no obligation, and expressly
disclaims any intention or obligation, to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by
applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-celebrates-summer-with-new-innovation-launching-across-canada-301843338.html
SOURCE Aurora Cannabis Inc.